AI Science Tracker
EN

MRI radiomics supports individualized Duchenne disease-trajectory reconstruction

University of Florida · 11 Nov 2026 · medicine

Discovery

MRI radiomics supports individualized Duchenne disease-trajectory reconstruction

Source check: Source checked. Not independent scientific confirmation.

Finding: XGBoost combined baseline MRI radiomics and clinical features to estimate muscle fat-fraction trajectory parameters in Duchenne muscular dystrophy. The final dataset included 98 unique participants, with 68 soleus and 64 vastus-lateralis analyses; held-out reconstructed trajectories had reported mean absolute errors of 0.04 and 0.06. Targets came from a previously fitted nonlinear mixed-effects model, rather than directly observed trajectory parameters. The retrospective analysis identified candidate progression subgroups but did not establish treatment response, prospective prediction or external generalizability.

Technology: XGBoost; MRI radiomics

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Participant-level 80:20 train/test split; XGBoost estimates NLME-derived trajectory descriptors from baseline radiomic/clinical features; reconstruction compared with observed fat fraction. Derived targets can shrink sparse subject trajectories; this is not new prospective clinical utility.
Test and result
Held-out participant trajectory reconstruction compared with observed longitudinal fat fractions.
Limitation / still unknown
Independent cohort validation, robustness of derived targets and benefits for clinical trial design remain unestablished.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13752581/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary full article Methods, Results and limitations plus Europe PMC bibliographic metadata; PMC full article..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.